1 |
dpavlin |
1.3 |
<table width="100%" border="0" cellspacing="0" cellpadding="0"> |
2 |
|
|
<tr> |
3 |
|
|
<td> |
4 |
|
|
<div align="center"><img src="t/vision.gif" width="171" height="16" vspace="10" hspace="5"></div> |
5 |
|
|
</td> |
6 |
|
|
</tr> |
7 |
|
|
<tr valign="top"> |
8 |
|
|
<td> PLIVA's Vision is to be a global pharmaceutical company bringing superior |
9 |
|
|
and innovative solutions to customer needs.</td> |
10 |
|
|
</tr> |
11 |
|
|
<tr> |
12 |
|
|
<td> |
13 |
|
|
<div align="center"><img src="t/pliva_core_pur.gif" width="269" height="16" vspace="10" hspace="5"></div> |
14 |
|
|
</td> |
15 |
|
|
</tr> |
16 |
|
|
<tr> |
17 |
|
|
<td> |
18 |
|
|
<div align="center"><img src="p/baby.gif" width="101" height="78" vspace="5" hspace="5"></div> |
19 |
|
|
</td> |
20 |
|
|
</tr> |
21 |
|
|
<tr> |
22 |
|
|
<td>PLIVA's core purpose is to improve quality of life and healthcare through |
23 |
|
|
the research and development, manufacturing and marketing of superior quality |
24 |
|
|
healthcare products. PLIVA is dedicated to bringing benefit not only to |
25 |
|
|
its customers but also to its shareholders, employees and the communities |
26 |
|
|
where it operates. </td> |
27 |
|
|
</tr> |
28 |
|
|
<tr> |
29 |
|
|
<td> </td> |
30 |
|
|
</tr> |
31 |
|
|
<tr> |
32 |
|
|
<td> |
33 |
|
|
<div align="center"><img src="t/pliva_copor_strategy.gif" width="269" height="16" vspace="10" hspace="5"></div> |
34 |
|
|
</td> |
35 |
|
|
</tr> |
36 |
|
|
<tr> |
37 |
|
|
<td> |
38 |
|
|
<div align="center"><img src="p/veslac.gif" width="101" height="78" vspace="5" hspace="5"></div> |
39 |
|
|
</td> |
40 |
|
|
</tr> |
41 |
|
|
<tr> |
42 |
|
|
<td> |
43 |
|
|
<div align=justify> |
44 |
|
|
<p style="TEXT-ALIGN: justify">Our corporate strategy has as its goal |
45 |
|
|
the rapid internationalization of the company's business. This involves |
46 |
|
|
all aspects of the business; its processes, people, sales, business-level |
47 |
|
|
standards, research and development activities, etc. The vision of the |
48 |
|
|
company as a global pharmaceuticals producer means that we must move |
49 |
|
|
beyond local and regional boundaries and expand business operations |
50 |
|
|
internationally. Recent acquisitions in Poland, the Czech Republic and |
51 |
|
|
the United Kingdom are only the most visible signs of this strategy. |
52 |
|
|
</p> |
53 |
|
|
</div> |
54 |
|
|
<div align=justify> |
55 |
|
|
<p style="TEXT-ALIGN: justify">Our strategic intent is to strengthen our |
56 |
|
|
Central and Eastern European market base, further internationalize our |
57 |
|
|
overall business activities, particularly into Western European |
58 |
|
|
and US markets, |
59 |
|
|
while maintaining our current leading position locally. Dynamic growth |
60 |
|
|
will be result of effective investments in research and development |
61 |
|
|
and targeted acquisitions in Western markets. </p> |
62 |
|
|
</div> |
63 |
|
|
<div align=justify> |
64 |
|
|
<p style="TEXT-ALIGN: justify">These ambitious goals will be underpinned |
65 |
|
|
by the further development and recruitment of expert staff, the creation |
66 |
|
|
of a multicultural environment and by fostering innovation and creativity. |
67 |
|
|
</p> |
68 |
|
|
</div> |
69 |
|
|
</td> |
70 |
|
|
</tr> |
71 |
|
|
<tr> |
72 |
|
|
<td> </td> |
73 |
|
|
</tr> |
74 |
|
|
<tr> |
75 |
|
|
<td height="11"> |
76 |
|
|
<div align="center"><img src="t/business.gif" width="287" height="33" vspace="10" hspace="5"></div> |
77 |
|
|
</td> |
78 |
|
|
</tr> |
79 |
|
|
<tr> |
80 |
|
|
<td> |
81 |
|
|
<div align=justify> |
82 |
|
|
<p style="TEXT-ALIGN: justify">Through its business philosophy of the |
83 |
|
|
total focus on the customer, PLIVA strives to understand customer |
84 |
|
|
needs far beyond that of its competition, but also, to match this understanding |
85 |
|
|
with an ability to respond rapidly with superior products and operational |
86 |
|
|
solutions that go significantly beyond customer expectations. </p> |
87 |
|
|
</div> |
88 |
|
|
<div align=justify> |
89 |
|
|
<p style="TEXT-ALIGN: justify"><i>In order to achieve its strategic objectives, |
90 |
|
|
PLIVA will develop its internal competencies. These include: </i> |
91 |
|
|
<ul> |
92 |
|
|
<li>Highly motivated people |
93 |
|
|
<li>Leadership |
94 |
|
|
<li>The development of a learning organization |
95 |
|
|
<li>A multicultural workforce |
96 |
|
|
<li>Risk management skills |
97 |
|
|
<li>Up-to-date E-business technologies |
98 |
|
|
<li>NCE/NBE research |
99 |
|
|
<li>Brand generic portfolio |
100 |
|
|
<li>Strong contacts with other R&D institutions |
101 |
|
|
<li>A Customer focus. </li> |
102 |
|
|
</ul> |
103 |
|
|
</div> |
104 |
|
|
</td> |
105 |
|
|
</tr> |
106 |
|
|
</table> |